期刊文献+

9L/F344大鼠脑胶质瘤模型的建立和增强MRI对种植瘤生长的动态观察 被引量:2

Dynamic observation of intracerebral glioma xenografs growth with enhanced MRI in 9L/F344 rats
原文传递
导出
摘要 目的建立9L/F344大鼠颅内脑胶质瘤模型,用增强MRI动态观察肿瘤生长。方法应用大鼠立体定向仪,在F344大鼠右侧尾状核区接种9L胶质瘤细胞1×105个;观察大鼠的生存状态、体重及活动等情况;分别于大鼠接种后第8、12、17、20、23天在小动物线圈下行大鼠头部强化MRI检查,动态观察肿瘤的生长情况;第20天,取肿瘤标本做组织病理学和神经胶质细胞纤维酸性蛋白(GFAP)免疫组化检查。结果大鼠平均生存期25d。大鼠成瘤率100%。增强MRI动态观察显示同一时期内大鼠的肿瘤体积均一,肿瘤的生长速度和形态符合胶质瘤生长特性;肿瘤组织病理学上接近人恶性脑胶质瘤的病理特点。结论该方法建立的9L/F344大鼠脑胶质瘤动物模型稳定性好,移植瘤生长均一,适合用于胶质瘤的基础研究。 Objective To establish the rat intracranial glioma xenografts model in 9L/Fischer 344(9L/F344) rats and observe dynamically the tumor growth with enhanced MRI. Methods The 9L gliosarcoma cells were injected stereotactically into the right caudate nucleus in 13 F344 rats. Each rat received 1 × 10^5 cells in a volume of 10 μl. The rat survival and body weight were observed. The growth of intracranial glioma xenografts was examined dynamically with enhanced MRI on the 8th , 12th , 17th , 20th, and 23rd day after implantation. On 20th day after implantation, 3 rats were sacrificed and the tumors were examined with histopathology and GFAP immunohistochemical stain. Results The average survival period of rats was 25 days. The xenograft formation rate was 100%. Enhanced MRI showed that the volumes of xenografts were uniform in the same period and the growth of xenografts was stable. Histopathology features of xenografts were close to those of human malignant glioma sarcoma. Conclusion The 9L/F344 rat intracerebral glioma model has been successfully established,which is growing uniformly and stably, and is suitable for the study on the biological characteristics and therapy Of glioma.
出处 《江苏医药》 CAS CSCD 北大核心 2012年第10期1133-1136,共4页 Jiangsu Medical Journal
关键词 胶质瘤 动物模型 F344大鼠 Glioma Animal model F344 rat
  • 相关文献

参考文献10

  • 1Westphal M,Lamszus K. The neurobiology of gliomas:fromcell biology to the development of therapeutic approaches[J]. Nat Rev Neurosci, 2011,12(9) : 495-508.
  • 2Bansal A,Shuyan W,Hara T,et al. Biodisposition and metab- olism of [(18)F] fluoroeholine in 9L glioma-cells and 9L glioma-bearing Fisher rats[J]. Eur J Nucl Med Mol Imaging, 2008,35(6) : 1192-1203.
  • 3Barker M, Hoshino T, Gurcay O, et al. Development of an animal brain tumor model and its response to therapy with 1, 3-bis(2-chloroethyl)-l-nitrosourea[J]. Cancer Res, 1973,33 (5):976-986.
  • 4姬西团,章翔,费舟,王西玲,梁景文,曹锐峰,赵明,林绿标,程光.颅内胶质瘤模型建立及肿瘤生长特征观察[J].中华神经外科疾病研究杂志,2004,3(1):5-8. 被引量:17
  • 5林健,王伟民,冼江,杨太成,詹纯列,王卓才,田野,吴迪,徐如祥.9L/F344大鼠脑胶质瘤模型的建立[J].中国微侵袭神经外科杂志,2003,8(8):359-362. 被引量:11
  • 6Parsa AT, Chakrabarti I, Hurley PT, el al. Limitations of the C6/Wistar rat intracerebral glioma model., implications for evaluating immunothempy [J]. Neurosurgery, 2000, 47 (4)993-1000.
  • 7Barth RF. Rats brain tumor models in experimental neuro- oncology: the 9L, C6, T9, F98, RG2 (1374), RT-2 and CNS-1 gliomas[J]. J Neurooncol, 1998,36 ( 1 ) : 91-102.
  • 8Ewing JR,Brown SL,Lu M,et al. Model selection in magnetic resonance imaging measurements of vascular permeability: Gadomer in a 9L model of rat cerebral tumor[J]. J Cereb Blood Flow Metab, 2006,26(3) : 310-320.
  • 9Fenstermacher JD, Knight R, Ewing JR, et al. Estima- ting blood-brain barrier opening in a rat model of hemorrhagic transformation with Patlak plots of Gd-DTPA contrast- enhance MRI[J]. Acta Neurochir,2003,86(Suppl):37-39.
  • 10Brown SL, Ewing JR, Kolozsvary A, et al. Magnetic reso- nance imaging of perfusion in rat cerebral 9L tumor after nicotinamide administration [J]. Int J Radiat Oncol Biol Phys, 1999,43 (3) : 627-633.

二级参考文献3

共引文献25

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部